Labshake search
Citations for R&D Systems :
1 - 50 of 67 citations for NRBP1 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... blocking anti-CXCR4 MAB21651 (247506, R&D Systems) or anti-CCR7 MAB3477 (4B12 ...
-
bioRxiv - Cell Biology 2022Quote: ... αCCR7 blocking antibody (R&D systems, 2-5μg/ml), rat immunoglobulin (Ig ...
-
bioRxiv - Neuroscience 2022Quote: ... Anti-Nrp2 function blocking antibody (AF2215, R&D Systems) was applied at a concentration of 10 µg/mL ...
-
bioRxiv - Physiology 2020Quote: ... PD-1 blocking antibody (R&D Systems/Techne, #AF1086) was included at the 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... blocked with Mouse on Mouse Blocking Reagent (R&D Systems) 2h and incubated with primary antibody ...
-
bioRxiv - Immunology 2022Quote: ... after blocking with Reagent Diluent (R&D System, ref DY006), 100-μL standard dilutions and samples were added to each well and incubated 2 hours at RT ...
-
bioRxiv - Biochemistry 2020Quote: ... Fluorogenic peptide substrates were obtained from R&D systems, where Mca-YVADAPK(Dnp)-OH (ES007 ...
-
bioRxiv - Neuroscience 2021Quote: ... + β-heregulin peptide (R&D Systems, Cat# 396-HB-050) + forskolin (Cayman Chemical ...
-
bioRxiv - Cell Biology 2019Quote: ... a fluorogenic peptide substrate of MMPs (R&D systems, USA). The fluorgenic substrate (5 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... recombinant control peptide (R&D systems, cat. #4460, Accession # P01863) is mouse melanoma cell line ...
-
bioRxiv - Systems Biology 2020Quote: ... mouse anti-IL-10R blocking antibody (10 µg/mL, R&D Systems) or mouse anti-TNFα Receptors 1 and 2 (10 µg/mL ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Synthetic Biology 2024Quote: ... 10% BSA ELISA reagent diluent/blocking solution concentrate (DY995, R&D systems) and TMB substrate (421501 ...
-
bioRxiv - Cancer Biology 2019Quote: ... and CXCR4 antagonist peptide AMD3100 were procured from R&D systems. All chemicals and antibodies were obtained from Sigma unless specified otherwise.
-
bioRxiv - Neuroscience 2022Quote: ... 10µg/ml of a VEGF function-blocking antibody (R&D Systems MAB9947-SP) was added to differentiation media and 10µg/ml of control IgG (Biolegend 403501 ...
-
bioRxiv - Bioengineering 2023Quote: ... and a TGFβ blocking antibody (20 µg mL-1, #MAB1835, R&D Systems). Trastuzumab (#MAB9589 ...
-
bioRxiv - Immunology 2023Quote: ... 30 µg/ml of anti-LOX-1 blocking antibody (polyclonal, R&D Systems) or goat IgG isotype (Biolegend ...
-
bioRxiv - Immunology 2023Quote: ... using either PCSK9 peptides or recombinant mPCSK9/hPCSK9 protein (R&D Systems) as the coating antigen ...
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Cancer Biology 2019Quote: ... Each well was supplemented with PDGFR-α blocking antibody (1:100; R&D Systems), or Imatinib (Seleckchem) ...
-
bioRxiv - Neuroscience 2021Quote: ... and incubated for 1 hour with blocking buffer (Reagent Diluent, R&D Systems, UK). Plates were washed 3 times with wash buffer and 100 ul of samples and standards were added (R&D Systems ...
-
bioRxiv - Systems Biology 2022Quote: ... avidin and biotin blocking reagents (HRP-DAB Cell &Tissue Staining Kit, R&D Systems) and washing in TBST in between each blocking step ...
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with RGDS peptide (10 μg/mL, R&D systems, MN, USA) (20 ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... incubated with the fluorogenic peptide substrate Z-FR-AMC (150 μM; R&D Systems) and measured at a fluorometer following a 0 to 30 min incubation (ƛEx = 390 nm ...
-
bioRxiv - Bioengineering 2021Quote: ... We performed the blocking experiment using an ACE2 polyclonal goat antibody (Cat # AF933; R&D systems) and CD147 (BSG ...
-
bioRxiv - Microbiology 2021Quote: ... surface blocking was conducted by incubated surfaces with anti-NgR1 antibody (R&D Systems; 100 µg/mL). Measurements were taken at a retraction velocity of 1 µm/s ...
-
bioRxiv - Neuroscience 2023Quote: ... for 5 min each time and subsequently incubated with blocking buffer (5% goat serum [R&D Systems, Minneapolis ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... the samples were incubated with primary anti-TRKB antibody (1:1000 in blocking buffer, #AF1494, R&D Systems) ON at 4°C ...
-
bioRxiv - Cancer Biology 2019Quote: ... human IFN-β blocking antibody (Clone AF814; R&D) and its corresponding isotype (Goat IgG, R&D Systems) were used at a concentration of 0.2 µg/ml ...
-
bioRxiv - Immunology 2022Quote: ... and in the indicated experiments with 20 μg/mL of blocking anti-NKG2D antibody (R&D systems MAB1547). Cells were then washed ...
-
bioRxiv - Immunology 2020Quote: ... and Alexa Fluor 594 labelled anti-human DAP10/HCST (R&D Systems, 1:500 v/v in blocking buffer) to stain for the cytoskeleton and DAP10 clusters respectively ...
-
bioRxiv - Immunology 2024Quote: ... and anti-B220 (Rat anti-mouse; monoclonal: RA3-6B2 clone; dilution 1:100 in blocking solution; R&D systems). Secondary antibody staining was performed for 50min at room temperature ...
-
bioRxiv - Cancer Biology 2020Quote: C57BL6/J male mice (#000664) received an intraperitoneal injection of 45μg anti-CCL20 blocking antibody (R&D Systems clone 114908) or rat IgG isotype control antibody (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... pH6.0 at 95°C followed by 1h blocking and incubation with pre-optimized primary anti-UCHL1 (MAB6007, R&D Systems) or anti-p53 (Dako ...
-
bioRxiv - Cancer Biology 2023Quote: ... blocking in 10% donkey serum was followed by overnight incubation at 4ºC with anti-CD31 (1:100; R&D Systems) and subsequent incubation with a fluorescent secondary antibody ...
-
bioRxiv - Molecular Biology 2020Quote: ... Tissue was permeabilized with 0.3% Triton X and quenching and blocking was performed using a cell and tissue staining kit (R&D Systems) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2019Quote: ... the cultures were supplemented with 20 μg/ml of a pan-vertebrate anti–TGF-β blocking antibody 1D11 (R&D Systems), alongside stimuli addition ...
-
bioRxiv - Immunology 2022Quote: ... BAL cells were treated for 2h before infection with an ACE2 blocking antibody at 10 μg/ml (AF933, R&D systems). SARS-CoV-2 was added to the cells at MOI 0.1 or 1 ...
-
bioRxiv - Immunology 2020Quote: Titration of blocking antibodies was performed by using static adhesion assays in which activated CD4+ T cells were allowed to adhere to either recombinant human ICAM/Fc or VCAM/Fc chimeras in the presence of blocking antibodies specific for integrin α4 (clone 2B4, R&D Systems) or integrin αL (clone TS1/22 ...
-
bioRxiv - Immunology 2023Quote: ... 3129), for CCR5, with Maraviroc (10 μM, 3756) and for blocking CXCR3 with AMG487 (10 μM, 4487) all from R&D Systems, at 37°C ...
-
bioRxiv - Microbiology 2023Quote: ... separated and blotted onto 0.2 μm nitrocellulose as above and incubated overnight at 4°C in blocking buffer supplemented with 2 μg/ml polyclonal sheep IgG anti-LL-37 (R&D Systems). Membranes were washed in wash buffer (PBS with 0.05% Tween ...
-
bioRxiv - Bioengineering 2023Quote: ... MVN and tumoroid treatments were administered over 4 days through daily media perfusion with an IL8 blocking antibody (20 µg mL-1, #MAB208, R&D Systems), Dexamethasone (5 µM ...
-
bioRxiv - Pathology 2023Quote: ... They were then first incubated with blocking solution for 1 hr and then with a mouse monoclonal anti-human CCR2 antibody (MAB150-SP; R&D Systems) overnight at 4°C ...
-
bioRxiv - Neuroscience 2023Quote: ... Neuropili-1 inhibition studies were repeated as described above for EG00229 using a goat polyclonal anti-NRP-1 blocking antibody (AF566; R&D Systems) at 1 µg/mL ...
-
bioRxiv - Microbiology 2024Quote: ... and treated with a blocking solution (dPBS +Ca2 +Mg2 with 2% (v/v) FBS) containing an anti-hTIM1(1:50-1:100, AF1750, R&D Systems) antibody ...
-
bioRxiv - Developmental Biology 2024Quote: ... Tissue was then incubated overnight at 4°C in blocking buffer with anti-E-cadherin (R&D Systems; Minneapolis, MN, USA; cat:MAB1838), anti-integrin-⍺-6 (Stem Cell Technologies ...
-
bioRxiv - Microbiology 2024Quote: ... the basolateral surfaces of the cells were pre-treated with blocking anti-integrin β1 antibody (25 µg/ml, R&D Systems, MAB17781) for 1h at 37°C ...